Offer - Urjas Oil for just Rs 1 X
Syndopa CR 250 Tablet (10) is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Syndopa CR 250 Tablet (10) have also been explained below.
The optimal dosage of Syndopa CR 250 Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Syndopa CR 250 Tablet (10) also has some side effects, the most common being Nausea or vomiting, Headache, Infection. Besides the aforementioned side effects, there are other adverse effects of Syndopa CR 250 Tablet (10) as well, which are listed below. Normally, these side effects of Syndopa CR 250 Tablet (10) are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Syndopa CR 250 Tablet (10)'s effect is Moderate during pregnancy and Mild for lactating mothers. Further, the section on Syndopa CR 250 Tablet (10) related warnings talks about Syndopa CR 250 Tablet (10)'s effects on the liver, heart and kidney.
Syndopa CR 250 Tablet (10) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Arrhythmia, Low Blood Pressure (Hypotension), Depression are examples of such conditions. Other contraindications of Syndopa CR 250 Tablet (10) have been discussed in the sections ahead.
Besides this, Syndopa CR 250 Tablet (10) may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Syndopa CR 250 Tablet (10) is considered not safe while driving, and is not addictive.
Syndopa CR 250 Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Syndopa CR 250 Tablet (10) safe for pregnant women?
Pregnant women may experience moderate side effects from Syndopa. It is best to stop taking Syndopa immediately and inform your doctor if you notice any discomfort.
Is the use of Syndopa CR 250 Tablet (10) safe during breastfeeding?
Side effects of Syndopa for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Syndopa CR 250 Tablet (10) on the Kidneys?
Syndopa rarely affects the kidneys.
What is the effect of Syndopa CR 250 Tablet (10) on the Liver?
Syndopa is rarely harmful for the liver.
What is the effect of Syndopa CR 250 Tablet (10) on the Heart?
Syndopa may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Syndopa CR 250 Tablet (10) unless your doctor advises you to do so -
Is this Syndopa CR 250 Tablet (10) habit forming or addictive?
Yes, you can get addicted to Syndopa CR 250 Tablet (10). It is essential that you take [medicine] only after doctor's recommendation.
Interaction between Food and Syndopa CR 250 Tablet (10)
Taking Syndopa CR 250 Tablet (10) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Syndopa CR 250 Tablet (10)
Taking alcohol with Syndopa CR 250 Tablet (10) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 426-429
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 54-55
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 279-281
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 429-430
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lodosyn® (carbidopa)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sinemet® (carbidopa-levodopa)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rytary® (carbidopa-levodopa)